Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission critical automation solutions to facilitate the manufacturing and release of healthcare products, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company's flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control, testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
종목 코드 RPID
회사 이름Rapid Micro Biosystems Inc
상장일Jul 15, 2021
CEOMr. Robert (Rob) Spignesi
직원 수163
유형Ordinary Share
회계 연도 종료Jul 15
주소25 Hartwell Avenue
도시LEXINGTON
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호02421
전화19783493200
웹사이트https://www.rapidmicrobio.com/
종목 코드 RPID
상장일Jul 15, 2021
CEOMr. Robert (Rob) Spignesi
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음